HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Information sources used by New South Wales cancer clinicians: a qualitative study.

AbstractBACKGROUND:
This study identified (i) information sources used by cancer clinicians to guide pharmacological treatments, (ii) utilization of, and opinions about, online information sources and (iii) clinicians' ability to access a specific cancer treatment protocol (escalated bleomycin, etiposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone (BEACOPP) for Hodgkin's Lymphoma). The work was carried out before activation of the Cancer Institute New South Wales Standard Cancer Treatment (CI-SCaT) programme.
METHODS:
We conducted semistructured interviews with a purposeful sample of senior and junior doctors, nurses and pharmacists treating adult cancer patients (n = 32) in eight New South Wales public hospitals.
RESULTS:
Information seeking processes are context specific and vary from clinician to clinician and ward to ward. Clinicians use human, electronic and printed information sources at, or close to, the point of patient care; however, experienced colleagues are preferred where information is needed quickly or in unfamiliar clinical situations. Barriers to using online cancer information are environmental (hardware, connection speeds, time), personal (poor computer literacy and lack of awareness of appropriate sites) and economic (costs of journal subscriptions). Just over half of participants were able to locate a specific cancer protocol and none of these protocols was fully consistent with CI-SCaT recommendations.
CONCLUSION:
There is no standardized approach to the pharmacological treatment of cancer patients in this sample of New South Wales clinicians. CI-SCaT will fill a gap with respect to standardizing oncology treatment. However, to ensure maximal CI-SCaT uptake, implementation plans should harness positive behavioural influences and attempt to modify the negative forces that act on hospital clinicians in their day-to-day work.
AuthorsE L Tan, H Stark, J S Lowinger, C Ringland, R Ward, S -A Pearson
JournalInternal medicine journal (Intern Med J) Vol. 36 Issue 11 Pg. 711-7 (Nov 2006) ISSN: 1445-5994 [Electronic] Australia
PMID17040357 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bleomycin
  • Procarbazine
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Bleomycin (therapeutic use)
  • Cyclophosphamide (therapeutic use)
  • Doxorubicin (therapeutic use)
  • Drug Information Services (classification, statistics & numerical data)
  • Etoposide (therapeutic use)
  • Female
  • Health Personnel (education, psychology)
  • Hodgkin Disease (drug therapy)
  • Hospitals, Public
  • Humans
  • Internet (statistics & numerical data)
  • Interviews as Topic
  • Male
  • Medical Oncology (education, statistics & numerical data)
  • Middle Aged
  • Neoplasms (drug therapy)
  • New South Wales
  • Online Systems (statistics & numerical data)
  • Prednisone (therapeutic use)
  • Procarbazine (therapeutic use)
  • Vincristine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: